WuXi Biologics revealed plans to build an integrated biologics development, clinical and commercial manufacturing center in the city of Shijiazhuang, capital of Hebei province in northern China. The new state-of-the-art biologics center will include process development labs, a clinical manufacturing facility with 5,000 liter bioreactor capacity and a commercial manufacturing facility with 48,000 liter bioreactor capacity, which will be built to meet cGMP standards of the U.S., the EU, and Chi...